Timeline

Jeanne Chiaravalli
Research Engineer
04 Jul 2022
publication

Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.

Read more
04 Jul 2022
publication

Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2

Read more
17 Jun 2022
news

New publication – Potent Human Broadly SARS-CoV-2 Neutralizing IgA and IgG Antibodies Effective Against Omicron BA.1 and BA.2

Read more
09 Mar 2022
publication

A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors.

Read more
21 Sep 2021
publication

Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential.

Read more
01 Sep 2021
publication

SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.

Read more
05 Jun 2015
team

Chemogenomic and Biological Screening Platform (PF-CCB)

Read more